Recombinant full length protein corresponding to Human MIG.
Database link: Q07325
Our Abpromise guarantee covers the use of ab17703 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|Neutralising||Use at an assay dependent concentration.
A concentration of 5.0-10.0 ug/ml is required to yield one-half maximal inhibition [ND50] of the biological activity of Human MIG (100 ng/ml).
|Sandwich ELISA||Use a concentration of 1 - 2 µg/ml.|
|WB||Use a concentration of 0.5 - 1 µg/ml. Predicted molecular weight: 14 kDa.|
ab17703 has not yet been referenced specifically in any publications.